Furthermore, concerning the implications of RORγt + Tregs, in inflammatory bowel disease it was shown that the capacity of IL-17 + RORγt + Tregs to suppress autologous T cell proliferation is reduced by approximately 60%14. This evidence concerns the gene IL17A and inflammatory bowel disease.